Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 10INDUSTRY 6OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 30Pancreatic Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Rectal Neoplasms 7Lung Neoplasms 7Gliosarcoma 7Glioblastoma 7Colonic Neoplasms 7Carcinoma, Hepatocellular 7Brain Neoplasms 7Esophageal Neoplasms 5Carcinoma, Renal Cell 5Astrocytoma 5Adenocarcinoma of Lung 5Salivary Gland Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Ovarian Epithelial 4Bile Duct Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Oligodendroglioma 3Esthesioneuroblastoma, Olfactory 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Stomach Neoplasms 2Pancreatic Intraductal Neoplasms 2Mesothelioma, Malignant 2Medulloblastoma 2Hereditary leiomyomatosis and renal cell cancer 2

Interventions

Fluorouracil 61Leucovorin 56Oxaliplatin 36Irinotecan 27Specimen Handling 23Biopsy 20Chemotherapy, Adjuvant 17Capecitabine 14Cetuximab 13Magnetic Resonance Spectroscopy 12Folfox protocol 12Bevacizumab 12Neoadjuvant Therapy 10sargramostim 6aldesleukin 6Melphalan 6Radiotherapy 5Floxuridine 5Cyclophosphamide 5dehydroftorafur 4X-Rays 4Nivolumab 4Interferon-alpha 4Immunoglobulin G 4Gemcitabine 4Disulfides 4Celecoxib 4fludarabine 3durvalumab 3Trastuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Colorectal Neoplasms × Erlotinib Hydrochloride × Clear all
NCT00049101 2013-06-24

Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡